BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26652175)

  • 1. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
    Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
    BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
    Li S; Su L; Lv G; Zhao W; Chen J
    Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
    Wu WC; Wang CY
    Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of anthropometric and biochemical indices in non-alcoholic fatty pancreas disease: a cross-sectional study.
    Xiao Y; Wang H; Han L; Huang Z; Lyu G; Li S
    BMJ Open; 2024 Apr; 14(4):e081131. PubMed ID: 38580356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
    Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
    Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
    Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
    Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
    Jermendy G
    Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between nonalcoholic fatty pancreas disease and diabetes.
    Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
    PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population.
    Wang CY; Ou HY; Chen MF; Chang TC; Chang CJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000297. PubMed ID: 24572250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty pancreas disease - practices for clinicians.
    Pinte L; Balaban DV; Băicuş C; Jinga M
    Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
    Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
    Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Implications of Fatty Pancreas: A Concise Review.
    Khoury T; Asombang AW; Berzin TM; Cohen J; Pleskow DK; Mizrahi M
    Dig Dis Sci; 2017 Oct; 62(10):2658-2667. PubMed ID: 28791556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical characteristics of fatty pancreas in Yangzhou, China: A cross-sectional study.
    Wang D; Yu XP; Xiao WM; Jiao XP; Wu J; Teng DL; Wu KY; Zhang M; Zhu QT; Liu XN; Ding YB; Lu GT
    Pancreatology; 2018 Apr; 18(3):263-268. PubMed ID: 29477252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of fatty pancreas by using EUS.
    Sepe PS; Ohri A; Sanaka S; Berzin TM; Sekhon S; Bennett G; Mehta G; Chuttani R; Kane R; Pleskow D; Sawhney MS
    Gastrointest Endosc; 2011 May; 73(5):987-93. PubMed ID: 21521567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience.
    Lesmana CRA; Gani RA; Lesmana LA
    JGH Open; 2018 Feb; 2(1):4-7. PubMed ID: 30483555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.
    Singh RG; Yoon HD; Wu LM; Lu J; Plank LD; Petrov MS
    Metabolism; 2017 Apr; 69():1-13. PubMed ID: 28285638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Nonalcoholic Fatty Pancreas by Endoscopic Ultrasonography.
    Sotoudehmanesh R; Tahmasbi A; Sadeghi A; Hosseini H; Mohamadnejad M
    Pancreas; 2019 Oct; 48(9):1220-1224. PubMed ID: 31593012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.